D, L., S, S., CB, S., R, I., V, F., D, G., . . . N, P. (2026). Alzheimer's Biomarkers and Visuospatial Cognition in Parkinson's Disease: Modification by α-Synuclein and Mediation of Age Effects. Movement disorders clinical practice. https://doi.org/10.1002/mdc3.70576
Chicago Style (17th ed.) CitationD, Ledingham, Sathyanarayana S, Stewart CB, Iredale R, Foster V, Galley D, Lad M, Baker MR, and Pavese N. "Alzheimer's Biomarkers and Visuospatial Cognition in Parkinson's Disease: Modification by α-Synuclein and Mediation of Age Effects." Movement Disorders Clinical Practice 2026. https://doi.org/10.1002/mdc3.70576.
MLA (9th ed.) CitationD, Ledingham, et al. "Alzheimer's Biomarkers and Visuospatial Cognition in Parkinson's Disease: Modification by α-Synuclein and Mediation of Age Effects." Movement Disorders Clinical Practice, 2026, https://doi.org/10.1002/mdc3.70576.